These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36777828)

  • 1. AGAP2-AS1/BRD7/c-Myc signaling axis promotes skin cutaneous melanoma progression.
    Wu L; Li S; Xu J; Shen C; Qian Q
    Am J Transl Res; 2023; 15(1):350-362. PubMed ID: 36777828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
    Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
    J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNA AGAP2-AS1/miR-628-5p/PTN Axis Modulates Proliferation, Migration, Invasion, and Apoptosis of Glioma Cells.
    Yan Y; Wang Y; Liu Y; Chen T; Zhu Y; Li H; Kong F
    Cancer Manag Res; 2020; 12():6059-6068. PubMed ID: 32801858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA AGAP2-AS1 interacts with IGF2BP2 to promote bladder cancer progression via regulating LRG1 mRNA stability.
    Zhao X; Chen J; Zhang C; Xie G; Othmane B; Kuang X; Liu B
    Cell Signal; 2023 Nov; 111():110839. PubMed ID: 37541640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N
    Xian J; Shang M; Dai Y; Wang Q; Long X; Li J; Cai Y; Xia C; Peng X
    J Dermatol Sci; 2022 Jan; 105(1):27-36. PubMed ID: 34930676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
    Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
    J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA AGAP2-AS1 accelerates cell proliferation, migration, invasion and the EMT process in colorectal cancer via regulating the miR-4,668-3p/SRSF1 axis.
    Li H; Guo S; Zhang M; Li L; Wang F; Song B
    J Gene Med; 2020 Nov; 22(11):e3250. PubMed ID: 32639657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
    Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
    Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
    Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
    Front Genet; 2020; 11():1030. PubMed ID: 33101368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA AGAP2-AS1 Promotes Cancer Cell Proliferation, Migration and Invasion in Colon Cancer by Forming a Negative Feedback Loop with LINC-PINT.
    Ji L; Chen S; Gu L; Wang J; Zhang X
    Cancer Manag Res; 2021; 13():2153-2161. PubMed ID: 33688258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma.
    An L; Huang J; Ge S; Zhang X; Wang J
    Comput Math Methods Med; 2022; 2022():1972516. PubMed ID: 35707044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis.
    Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S
    J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A.
    Ji H; Wang J; Lu B; Li J; Zhou J; Wang L; Xu S; Peng P; Hu X; Wang K
    Mol Med; 2021 Feb; 27(1):10. PubMed ID: 33522895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway.
    Zheng Y; Lu S; Xu Y; Zheng J
    Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA TTN-AS1 facilitates tumorigenesis and metastasis by maintaining TTN expression in skin cutaneous melanoma.
    Wang Y; Li D; Lu J; Chen L; Zhang S; Qi W; Li W; Xu H
    Cell Death Dis; 2020 Aug; 11(8):664. PubMed ID: 32820147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
    Luo W; Li X; Song Z; Zhu X; Zhao S
    Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.
    Hong S; Yan Z; Song Y; Bi M; Li S
    Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA AGAP2-AS1 promotes cell proliferation and invasion through regulating miR-193a-3p/LOXL4 axis in laryngeal squamous cell carcinoma.
    Ren P; Niu X; Zhao R; Liu J; Ren W; Dai H; Chen J; Yan J; Li B; Shao Y; Bai Y; Han P
    Cell Cycle; 2022 Apr; 21(7):697-707. PubMed ID: 35113007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.